Akso Health Group
Akso Health Group (HX) Stock Overview
Explore Akso Health Group’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
53.4M
P/E Ratio
-3.09
EPS (TTM)
$-1.22
ROE
-0.13%
HX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Akso Health Group (HX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $2.47.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.09 and a market capitalization of 53.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.